• Info
  • Insider Ownership

Insider Trading & Ownership of SMITH ALAN E

Location
Cambridge, MA
Summary
The estimated value of insider holdings of SMITH ALAN E is at least $29,293 dollars as of 26 Jul 2021. SMITH ALAN E is the Director of Candel Therapeutics, Inc. and owns shares of Candel Therapeutics, Inc. (CADL) stock worth about $29.3K.
Signature
/s/ Alan E. Smith
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow SMITH ALAN E and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • SMITH ALAN E has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $29,293.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Candel Therapeutics, Inc. ($29,293).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of SMITH ALAN E

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CADL Candel Therapeutics, Inc. Director $29,293 26 Jul 2021

Insider Transactions Reported by SMITH ALAN E:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored